N-acetylaspartate and N-acetylaspartylglutamate deficits in superior temporal cortex in schizophrenia and bipolar disorder: A postmortem study

Biological Psychiatry

Volumn 53, Issue 12, 2003, Pages 1138-1141

  Nudmamud, Sutisa ^a,b   Reynolds, Lindsay M ^a   Reynolds, Gavin P ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b NARESUAN UNIVERSITY   (Thailand)

Author keywords

Bipolar disorder; N acetylaspartate; N acetylaspartylglutamate; Postmortem; Schizophrenia; Superior temporal cortex

Indexed keywords

N ACETYLASPARTIC ACID; N ACETYLASPARTYLGLUTAMIC ACID;

ARTICLE; AUTOPSY; BIPOLAR DISORDER; BRAIN DYSFUNCTION; BRAIN TISSUE; CONTROLLED STUDY; FRONTAL CORTEX; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SCHIZOPHRENIA; TEMPORAL CORTEX;

EID: 0037838880     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(02)01742-0     Document Type: Article

References (22)

1. Battistuta J., Bjartmar C., Trapp B.D. Postmortem degradation of N-acetyl aspartate and N-acetyl aspartylglutamate An HPLC analysis of different rat CNS regions . Neurochem Res. 26:2001;695-702.
2. Bertolino A., Callicott J.H., Elman I., Mattay V.S., Tedeschi G., Frank J.A., et al. Regionally specific neuronal pathology in untreated patients with schizophrenia A proton magnetic resonance spectroscopic imaging study . Biol Psychiatry. 43:1998;641-648.
3. Bertolino A., Nawroz S., Mattay V.S., Barnett A.S., Duyn J.H., Moonen C.T.W., et al. Regionally specific pattern of neurochemical pathology in schizophrenia as assessed by multislice proton magnetic resonance spectroscopic imaging. Am J Psychiatry. 153:1996;1554-1563.
4. Buckley P.F., Moore C., Long H., Larkin C., Thompson P., Mulvany F., et al. 1H-magnetic resonance spectroscopy of the left frontal lobes in schizophrenia Clinical, neurodevelopmental, and cognitive correlates . Biol Psychiatry. 36:1994;792-800.
5. Deicken R.F., Pegues M., Amend D. Reduced hippocampal N-acetylaspartate without volume loss in schizophrenia. Schizophr Res. 37:1999;217-233.
6. Deicken R.F., Zhou L., Schuff N., Fein G., Weiner M.W. Hippocampal neuronal dysfunction in schizophrenia as measured by proton magnetic resonance spectroscopy. Biol Psychiatry. 43:1998;483-488.
7. De Stefano N., Matthews P., Antel J.P., Preul M., Francis G., Arnold D.L. Chemical pathology of acute demyelinating lesions and its correlations with disability. Ann Neurol. 38:1995;901-909.
8. Ende G., Braus D.F., Walter S., Weber-Fahr W., Soher B., Maudsley A.A., et al. Effects of age, medication, and illness duration on the N-acetylaspartate signal of the anterior cingulate region in schzophrenia. Schizophr Res. 41:2000;389-395.
9. Fukuzako H., Takeuchi K., Hokazono Y., Fukuzako T., Yamada K., Hashiguchi T., et al. Proton magnetic resonance spectroscopy of the left medial temporal and frontal lobes in chronic schizophrenia Preliminary report . Psychiatry Res Neuroimaging. 61:1995;193-200.
10. Kegeles L.S., Shungu D.C., Anjilvel S., Chan S., Ellis S.P., Xanthopoulos E., et al. Hippocampal pathology in schizophrenia Magnetic resonance imaging and spectroscopy studies . Psychiatry Res. 98:2000;163-175.
11. Neale J.H., Bzdega T., Wroblewska B. N-Acetylaspartylglutamate The most abundant peptide neurotransmitter in the mammalian central nervous system . J Neurochem. 75:2000;443-452.
12. Nudmamud S., Reynolds G.P. Increased density of glutamate/N-methyl-D-aspartate receptors in superior temporal cortex in schizophrenia. Neurosci Lett. 304:2001;9-12.
13. Omori M., Murata T., Kimura H., Koshimoto Y., Kado H., Ishimori Y., et al. Thalamic abnormalities in patients with schizophrenia revealed by proton magnetic resonance spectroscopy. Psychiatry Res. 98:2000;155-162.
14. Pearlson G.D. Superior temporal gyrus and planum temporale in schizophrenia A selective review . Prog Neuropsychopharmacol Biol Psychiatry. 21:1997;1203-1229.
15. Rango M., Spagnoli D., Tomei G., Bamonti F., Scarlato G., Zetta L. Central nervous system transsynaptic effects of acute axonal injury A 1H magnetic resonance spectroscopy study . Magn Reson Med. 33:1995;595-600.
16. Renshaw P.F., Yurgelun-Todd D.A., Tohen G.S., Cohen B.M. Temporal lobe proton magnetic resonance spectroscopy of patients with first-episode psychosis. Am J Psychiatry. 152:1995;444-446.
17. Torrey E.F., Webster M., Knable M., Johnston N., Yolken R.H. The stanley foundation brain collection and neuropathology consortium. Schizophr Res. 44:2000;151-155.
18. Tsai G., Passani L.A., Slusher B.S., Carter R., Baer L., Kleinman J.E., et al. Abnormal excitatory neurotransmitter metabolism in schizophrenic brains. Arch Gen Psychiatry. 52:1995;829-836.
19. Tsai G., van Kammen D.P., Chen S., Kelley M.E., Grier A., Coyle J.T. Glutamatergic neurotransmission involves structural and clinical deficits of schizophrenia. Biol Psychiatry. 44:1998;667-674.
20. Urenjak J., Williams S., Gadian D., Noble M. Proton nuclear magnetic resonance spectroscopy unambiguously identifies different neural cell types. J Neurosci. 13:1993;981-989.
21. Winsberg M.E., Sachs N., Tate D.L., Adalsteinsson E., Spielman D., Ketter T.A. Decreased dorsolateral prefrontal N-acetylaspartate in bipolar disorder. Biol Psychiatry. 47:2000;475-481.
22. Yurgelun-Todd D.A., Renshaw P.F., Gruber S.A., Ed M., Waternaux C., Cohen B.M. Proton magnetic resonance spectroscopy of the temporal lobes in schizophrenics and normal controls. Schizophr Res. 19:1996;55-59.